Press Releases

Notice of Cipher Pharmaceuticals Q4 and Year-End 2017 Conference Call

MISSISSAUGA, ON, Feb. 9, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q4 and full-year 2017 financial results conference call on Wednesday, February 28, 2018.

Q4 AND YEAR-END 2017 CONFERENCE CALL

WHEN: Wednesday, February 28, 2018 at 8:30AM ET

CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2Bfo3oU. An archived replay of the webcast will be available for 90 days.

About Cipher Pharmaceuticals Inc.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America.  For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

For further information: Craig Armitage, LodeRock Advisors, (416) 347-8954, [email protected]